Dr Kimambo welcomed as new acting Country Representative to Kenya

Nairobi - Dr Neema Rusibamayila Kimambo, the new acting WHO Representative to Kenya, held her first official meeting with Cabinet Secretary for Health Honourable Aden Duale on 4 February 2026. The meeting set the agenda for 2026 and reaffirmed WHO's commitment to supporting the Ministry of Health.

Improving lives of people affected by lymphatic filariasis in Kenya

Nairobi—Kenya is accelerating efforts to eliminate lymphatic filariasis, commonly known as elephantiasis, as a public health problem by 2027. Yearly mass drug administration carried out between 2016 and 2022 have effectively halted transmission of the disease—a painful and disfiguring mosquito-borne infection that can cause permanent disability.

Protecting communities to eliminate lymphatic filariasis in Kenya

NairobiIn Kenya, regular mass drug administration is protecting a new generation from the effects of lymphatic filariasis, commonly known as elephantiasis ‒ a neglected tropical disease that affects the lymphatic system and can lead to the abnormal enlargement of body parts, causing pain, severe disability and social stigma.